Improving Access to Essential Medicines for Mental, Neurological, and Substance Use Disorders in Sub-Saharan Africa: Workshop Summary (2014)
Chapter: Appendix D: Registered Attendees
Michelle Akande
Johnson & Johnson
Albert Akpalu
Korle Bu Teaching Hospital
Atalay Alem
Addis Ababa University
Alemu Asgedom
Federal Prison Administration
Yonas Beheretibeb
Addis Ababa University
Desalegn Bekele
Addis Ababa University
François Bompart
Sanofi
Andrea Bruni
World Health Organization
Dan Chisholm
World Health Organization
Pamela Collins
U.S. National Institute of Mental Health
Tarun Dua
World Health Organization
Margaret Ewen
Health Action International
Tedla Giorgis
Ministry of Health, Ethiopia
Oye Gureje
University of Ibadan
Alemayehu Haile
Government of the District of Columbia
Charlotte Hanlon
Addis Ababa University
Hans Hogerzeil
Groningen University
Steven Hyman
The Broad Institute of MIT and Harvard University
Mapoko Ilondo
Novo Nordisk
Eric Amin Jeje
Gefersa Mental Health Rehabilitation Center
Frances Jensen
University of Pennsylvania Health System
Kidane Kiros
I-TECH
Thomas Kresina
U.S. Substance Abuse and Mental Health Services Administration
Gebrezgi Gidey Lemma
Mekelle University
Jafary Liana
Management Sciences for Health
Negussu Mekonnen
Management Sciences for Health
David Michelson
Merck Research Laboratories
Mamuye Mussie
Mekelle Hospital
Eva Ombaka
St. John’s University of Tanzania
Atul Pande
GlaxoSmithKline
Ismet Samji
GlaxoSmithKline
Manuel Sibhatu
I-TECH
Abebe Solomon
Addis Ababa University
Hailu Tadeg
Management Sciences for Health
Solomon Teferra
Addis Ababa University
Seblework Teklehaymanot
Ministry of Health, Ethiopia
Markos Tesfaye
Jimma University
Gert Wourters
Universitair Psychiatrisch Centrum Kortenberg
Prashant Yadav
William Davidson Institute
Lidya Yismaw
Gefersa Mental Health Rehabilitation Center
Paul Zintl
Harvard Medical School
